Tempest Therapeutics, Inc. (TPST)

Tempest Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	30.27	39.23	31.23	51.83	18.82
Cash & Short-Term Investments	30.27	39.23	31.23	51.83	18.82
Cash Growth	-22.84%	25.62%	-39.74%	175.39%	480.15%
Receivables	-	-	-	-	0.26
Prepaid Expenses	1.21	0.7	0.7	0.95	0.25
Other Current Assets	-	0.43	1.02	16.19	0.5
Total Current Assets	31.47	40.36	32.95	68.96	19.83
Property, Plant & Equipment	9.53	10.79	12.71	4.16	2.99
Other Long-Term Assets	0.49	0.45	0.43	0.11	0.05
Total Assets	41.49	51.6	46.09	73.24	22.86
Accounts Payable	2.45	0.85	1.11	0.99	1.07
Accrued Expenses	4.55	3.33	4.31	2.59	1.44
Current Portion of Long-Term Debt	6.35	4.29	-	-	-
Current Portion of Leases	0.87	0.95	1.41	1.44	0.71
Other Current Liabilities	-	-	0.45	15	-
Total Current Liabilities	14.22	9.41	7.28	20.03	3.22
Long-Term Debt	-	6.26	10.37	15.07	-
Long-Term Leases	8.14	9.16	10.33	2.03	1.73
Total Liabilities	22.36	24.84	27.98	37.12	4.95
Common Stock	0.04	0.02	0.01	0.01	0
Additional Paid-In Capital	226.19	192.01	153.87	136.17	2.97
Retained Earnings	-207.11	-165.26	-135.77	-100.06	-71.76
Total Common Equity	19.13	26.77	18.11	36.12	-68.79
Shareholders' Equity	19.13	26.77	18.11	36.12	17.91
Total Liabilities & Equity	41.49	51.6	46.09	73.24	22.86
Total Debt	15.37	20.66	22.11	18.54	2.44
Net Cash (Debt)	14.9	18.57	9.12	33.29	16.38
Net Cash Growth	-19.74%	103.70%	-72.62%	103.24%	1761.48%
Net Cash Per Share	0.53	1.20	0.79	8.78	34.99
Filing Date Shares Outstanding	43.97	22.19	10.56	7.17	1.03
Total Common Shares Outstanding	43.97	22.05	10.52	6.91	1.03
Working Capital	17.25	30.95	25.67	48.94	16.6
Book Value Per Share	0.43	1.21	1.72	5.23	-66.68
Tangible Book Value	19.13	26.77	18.11	36.12	-68.79
Tangible Book Value Per Share	0.43	1.21	1.72	5.23	-66.68
Machinery	-	1.63	1.54	1.1	0.82
Leasehold Improvements	-	0.24	0.88	0.84	0.75

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q